These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34823241)

  • 1. Late-Life Depression, Cognitive Impairment, and Relationship with Alzheimer's Disease.
    Invernizzi S; Simoes Loureiro I; Kandana Arachchige KG; Lefebvre L
    Dement Geriatr Cogn Disord; 2021; 50(5):414-424. PubMed ID: 34823241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-Life Depression versus Amnestic Mild Cognitive Impairment: Alzheimer's Disease Incidence in 4 Years of Follow-Up.
    Lauriola M; Mangiacotti A; D'Onofrio G; Cascavilla L; Paris F; Ciccone F; Greco M; Paroni G; Seripa D; Greco A
    Dement Geriatr Cogn Disord; 2018; 46(3-4):140-153. PubMed ID: 30199883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential associations between depression and cognitive function in MCI and AD: a cross-sectional study.
    Lee CH; Kim DH; Moon YS
    Int Psychogeriatr; 2019 Aug; 31(8):1151-1158. PubMed ID: 30696505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.
    Butters MA; Sweet RA; Mulsant BH; Ilyas Kamboh M; Pollock BG; Begley AE; Reynolds CF; DeKosky ST
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1075-81. PubMed ID: 14677138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in remitted late-life depression is not associated with Alzheimer's disease-related CSF biomarkers.
    Loureiro JC; Stella F; Pais MV; Radanovic M; Canineu PR; Joaquim HPG; Talib LL; Forlenza OV
    J Affect Disord; 2020 Jul; 272():409-416. PubMed ID: 32553384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers.
    Steenland K; Karnes C; Seals R; Carnevale C; Hermida A; Levey A
    J Alzheimers Dis; 2012; 31(2):265-75. PubMed ID: 22543846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.
    Diniz BS; Reynolds CF; Begley A; Dew MA; Anderson SJ; Lotrich F; Erickson KI; Lopez O; Aizenstein H; Sibille EL; Butters MA
    J Psychiatr Res; 2014 Feb; 49():96-101. PubMed ID: 24290367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
    Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between urinary Alzheimer-associated neuronal thread protein and cognitive impairment in late-life depression: a controlled pilot study.
    Zhang QE; Ling S; Li P; Zhang S; Ng CH; Ungvari GS; Wang LJ; Lee SY; Wang G; Xiang YT
    Int J Biol Sci; 2018; 14(11):1497-1502. PubMed ID: 30263001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.
    Lee GJ; Lu PH; Hua X; Lee S; Wu S; Nguyen K; Teng E; Leow AD; Jack CR; Toga AW; Weiner MW; Bartzokis G; Thompson PM;
    Biol Psychiatry; 2012 May; 71(9):814-21. PubMed ID: 22322105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
    Johnson LA; Hall JR; O'Bryant SE
    PLoS One; 2013; 8(7):e68848. PubMed ID: 23874786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.